Log In
Print
BCIQ
Print
Print this Print this
 

BGJ398

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionSelective inhibitor of Fibroblast growth factor receptor (FGFR)
Molecular Target Fibroblast growth factor (FGF) receptor (FGFR)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today